J-Lex

Adalimumab BS Subcutaneous Injection 40mg Syringe 0.4mL “CTNK”

Code3999472G2020
Standard40mg 0.4mL 1 tube
Ingredient Adalimumab (genetical recombination) [adalimumab follow-on 4]
Maker Nippon Kayaku

Adalimumab BS Subcutaneous Injection 40mg Syringe 0.4mL “CTNK”, from Nippon Kayaku, contains Adalimumab (genetical recombination) [adalimumab follow-on 4] and is identified by YJ code 3999472G2020. This biosimilar injectable is supplied as a 40mg 0.4mL 1 tube.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for inquiries about this medicine (English support available).

More with the same ingredient

Adalimumab BS Subcutaneous Injection 40mg Syringe 0.4mL “CTNK”

Need more detailed information?

More with the same ingredient

Adalimumab BS subcutaneous injection 20mg syringe 0.2mL “CTNK”

Adalimumab BS Subcutaneous Injection 80mg Syringe 0.8mL “CTNK”

Adalimumab BS Subcutaneous Injection 40mg Pen 0.4mL “CTNK”

Adalimumab BS Subcutaneous Injection 80mg Pen 0.8mL “CTNK”

More from this manufacturer

Breo S ointment 5 mg/g

Dexamethasone oral ointment 0.1% “NK”

Millis tape 5mg

Bevacizumab BS IV infusion 100mg “CTNK”

Bevacizumab BS IV infusion 400mg “CTNK”

Portraza IV infusion 800mg

Trastuzumab BS IV infusion 60mg “NK”

Trastuzumab BS IV infusion 150mg “NK”

For Healthcare Professionals